| Literature DB >> 32538312 |
Rebecca Mary Meiring1,2, Kento Tanimukai1, Lynley Bradnam1.
Abstract
Objective: Adequate physical activity following cardiac rehabilitation (CR) is required to reduce secondary cardiovascular disease risk. The aim of this review and meta-analysis was to determine the effect of exercise-based CR on objectively measured physical activity (PA) and sedentary behavior (SB) comparing pre- to postintervention, pre- to postchange compared to a control group, and in a longer term follow-up.Entities:
Keywords: accelerometer; cardiac rehabilitation; exercise; physical activity; sedentary behavior
Mesh:
Year: 2020 PMID: 32538312 PMCID: PMC7297483 DOI: 10.1177/2150132720935290
Source DB: PubMed Journal: J Prim Care Community Health ISSN: 2150-1319
Figure 1.Flowchart showing the method of selection of studies included in the final analysis.
Study Characteristics.
| Authors (year) | Study design | Intervention duration | No. of participants | Gender, male/female (n/n) or % male | Age,[ | BMI, kg/m2 | Diagnosis |
|---|---|---|---|---|---|---|---|
| van den Berg-Emons et al (2004) | RCT | 3 months | IG 18; CG 16 | IG 12/6; CG 13/3 | IG 58.6 (12.1); CG 58.6 (10.6) | IG 25.2 (3.0); CG 30.1 (4.6) | Stable heart failure (primarily systolic dysfunction, NYHA class II/III); left ventricular ejection fraction < 40%: ischemic heart disease, idiopathic dilated cardiomyopathy, hypertension, nonobstructive valve disease |
| Stevenson et al (2009) | Prospective study | 4-6 weeks | 22 | 14/6 | 65.6 (13.2) | 29.1 (4.6) | Patients who had undergone percutaneous coronary intervention or coronary artery bypass graft |
| Cowie et al (2011) | RCT | 8 weeks | 60 randomized to hospital-based (n = 20), home-based (n = 20) or control group (n = 20) | Hospital 16/4; home 18/2; control 17/3 | Hospital 71.2 [59-85]; home 65.5 [35-82]; control 61.4 [39-79] | [ | Left ventricular systolic dysfunction on echo, clinically stable for 1 month, on optimized medication dose |
| Witham et al (2012) | RCT | 8-week hospital-based then 16 week home-based | IG 53; CG 54 | IG 35/18; CG 37/17 | IG 80.4 (5.8); CG 79.5 (4.9) | NR | Confirmed diagnosis of heart failure due to left ventricular systolic dysfunction (NYHA classes II and III) and a history of signs and symptoms of congestive heart failure |
| Borland et al (2014) | RCT | 3 months | IG 25; CG 23 | IG 20/5; CG 18/5 | IG 70 (6); CG 71 (9) | NR | Stable chronic heart failure NYHA class II-III |
| Oliveira et al (2014) | RCT | 8 weeks | IG 47; CG 45 | IG 40/7; CG 37/8 | IG 54.8 (10.6); CG 58.6 (10.7) | IG 27.0 (3.6); CG 27.5 (3.3) | 4 weeks postacute myocardial infarction |
| Frederix et al (2015a) | Multicenter, prospective RCT | 18 weeks | IG 69; CG 70 | IG 59/10; CG 55/15 | IG 61 (9); CG 61 (8) | IG 28 (5); CG 28 (4) | Coronary artery disease and treated with percutaneous coronary intervention or coronary artery bypass grafting, chronic heart failure (NYHA class I, II, and III) with reduced ejection fraction or preserved ejection fraction |
| Frederix et al (2015b) | Prospective RCT | Centre-based = 12 weeks. Internet telerehabilitation = 24 weeks | IG 32; CG 34 (all randomized participants = 80, 40 in each group) | [ | IG 58 (9); CG 63 (10) | IG 29.1 (4.9); CG 26.8 (3.6) | Acute coronary syndrome or coronary artery bypass graft |
| Yates et al (2015) | Repeated-measures design of pilot study with an embedded RCT | 3 months | 35 couples randomized into 2 groups, usual care and PaTH groups. Final analysis included: IG 18 couples; CG 17 couples[ | IG 15/2; CG 13/4 | IG 64 [33-77] years; CG 66 [40-77] years | NR | Coronary artery bypass graft and partners required to be married or living with the patient >1 year, both classified as low to moderate risk for the occurrence of cardiac events during exercise |
| Ramadi et al (2016) | Prospective 2-arm repeated-measures study | Patients entering 2 CR programs: Traditional (T) 12 weeks; Fast-track (FT) 8 weeks | T 24; FT 20 | T 17/7; FT 17/3 | T 61 (10); FT 64 (7) | T 28.6 (5.1); FT 27.9 (4.1) | Patients referred to CR with a diagnosis of coronary artery disease |
| Ribeiro et al (2017) | Subanalysis of 2 prospective RCTs | 8 weeks | IG 25; CG 25 | IG 23/2; CG 20/5 | IG 54 (9); CG 58 (9) | IG 28.9 (4.0); CG 27.8 (4.0) | Acute myocardial infarction |
| ter Hoeve et al (2017) | Prospective cohort study | 10-13 weeks | 135 | 106 (29) | 58.8 (8.5) | 28.0 (3.8) | Acute coronary syndrome |
| Prince et al (2018) | Single center, 2-arm pilot RCT | 8 weeks | IG 17; CG 21 | IG 10/7; CG 13/8 | IG 62.4 (10.7); CG 61.5 (9.7) | IG 28.7 (25.7, 31.6); CG 30.5 (28.0, 32.9) | Coronary artery disease and referred to CR |
| ter Hoeve et al (2018) | RCT | 3 months | CR and face-to face counseling (CR + F): 161, CR and telephonic counselling (CR + T): 165. CR only: 163 | CR + F 129/32; CR + T 141/24; CR only 131/32 | CR + F 58.8 (9); CR + T 58.2 (9); CR only 59.1 (8) | NR | Acute coronary syndrome |
| Freene et al (2019) | Prospective cohort design, phase II CR trial | 6 weeks | 72 | 79% | 64.2 (9.6) | 30.1 (5.0) | Stable coronary heart disease and receiving treatment with or without revascularization |
Abbreviations: CR, cardiac rehabilitation; RCT, randomized controlled trial; IG, intervention group; CG, control group; NYHA, New York Heart Association; NR, not reported.
Age reported as mean (SD) or mean [range].
Standard deviation not reported.
Not reported if % is for baseline number of participants or those who completed the intervention.
Data for patients only and not spouses.
Figure 2.Heat map of changes in physical activity (PA) and sedentary behavior (SB) immediately after and at the long-term follow-up after cardiac rehabilitation by type of study. Whether each study included a behavior intervention or counseling in addition to exercise as part of their cardiac rehabilitation is also included. Red, no; Green, yes; no color, not applicable/not reported.
Study Accelerometer Protocols and Main Activity Outcome Findings.
| Authors (year) | Accelerometer name | Duration and placement of accelerometer wear | PA and/or SB outcome of interest | Main activity findings |
|---|---|---|---|---|
| van den Berg-Emons et al (2004) | Activity Monitor (AM, Temec Instruments, Kerkrade, The Netherlands). | 2 days | Everyday PA (duration, rate, and moment of occurrence of static activities, dynamic activities, and transitions between posture. Pretreatment (t0) and posttreatment: after 3-month intervention (t3). | No difference in the between-group change in everyday PA outcomes. |
| Stevenson et al (2009) | Actigraph GT1M | During entry week and exit week for 7 days. Valid day = 480 minutes of recorded PA data. Nonwear 60 or more minutes of consecutive zeroes. Minimum 4 days for valid data, including minimum 1 CR day 1 non-CR day and 1 weekend day. | Total activity (counts per observation minute), light intensity PA (min/d), MVPA (min/d) and inactivity time (<260 cpm; % of total observation minutes per day) were recorded for CR and non-CR days from entry to exit (4-6 weeks). | Overall activity counts greater on CR days (224.0 (15.6)) vs non-CR days (188.2 (14.5)); |
| Cowie et al (2011) | activPAL (PAL Technologies Ltd, Glasgow, Scotland) | Anterior thigh. One week prior to start of CR, immediately on completion of CR and 6 months follow-up after cessation of CR (subgroup analysis), 24-hour protocol. | Time spent in upright position, mean number of steps per day. Walking pattern: mean steps per day taken and mean cadence during extra-long (>500 steps), long (100-499 steps), moderate (20-99 steps), and short (<20 steps) walks. | No within- or between-group difference in upright duration or steps per day for all groups. No within- or between-group differences in cadence of walking patterns. At 8 weeks, hospital-based group showed significant increase in steps/day for extra-long (399 steps/day) and long (530 steps/day) walks. Within-group change in steps/day was significantly greater for hospital compared with control for extra-long ( |
| Witham et al (2012) | RT3 triaxial accelerometer (Stay Healthy Inc) | Placement NR. Worn during waking hours for 7 days at baseline, 8 weeks, and 24 weeks. | Six-minute walk test time. Secondary outcomes of PA were total activity counts | No difference in change in activity counts between IG and CG for baseline to 8 weeks or baseline to 24 weeks. |
| Borland et al (2014) | KeepWalking LS2000 pedometer (KeepWalking Scandanavia, Klamar, Sweden). | Waist. 7 days at baseline and at 3 months. Overweight participants placed pedometer on ankle. Worn for entire day and self-record daily number of steps in a diary and reset device to zero each morning. | Pedometer measured step count. Secondary outcomes of self-reported PA (IPAQ), physical fitness (symptom-limited cycle ergometer test), 6-minute walk test, muscle endurance, unilateral isoinertial shoulder flexion, bilateral isometric shoulder abduction, unilateral isoinertial heel-lift, health-related quality of life. | No difference in steps per day between intervention and control group after 3 months. |
| Oliveira et al (2014) | ActiGraph GT1M | Right hip. Worn for 7 days except during sleeping, bathing, and water activities. Used Troiano cut-points to reduce data to time spent in PA intensities. | Total PA (cpm), sedentary, light, and MVPA time (min/d). | A significant treatment × time interaction was observed for sedentary behavior, but no difference in the change in SB between IG and CG at final assessment. No difference in change in time spent in light and MVPA. |
| Frederix et al (2015a) | Yorbody accelerometer (Belgium)—no additional detail provided. | Accelerometer placement not mentioned, worn continuously from beginning of CR to end (12 weeks). Accelerometer provided daily recordings of aerobic (defined as sustained activity at ≥60 steps/min for more than 10 minutes | Daily number of aerobic steps defined as ≥60 steps/min during at least 10 minutes without stopping; regular daily steps defined as steps at <60 steps/min; number of total daily steps = sum of aerobic and regular steps. Exercise tolerance, biochemical markers of cardiometabolic health. Measured at start of Telerehab study (6 weeks after initiation of phase II CR), 6 weeks into Telerehab study and at end of Telerehab study (week 18). | Correlations between aerobic daily step count and increase in VO2peak during follow-up ( |
| Frederix et al (2015b) | Yorbody (no manufacturer details provided). | From beginning of Telerehab II study, 6 weeks of intervention and at 18 weeks after intervention start. Worn for 7 consecutive days during waking hours and removed for water activities. No data reduction methods provided. | Primary measures were peak aerobic capacity (VO2peak) at baseline, after 6 weeks and 24 weeks. Secondary measures were duration of physical activity levels gathered from steps/min. | Total daily steps in IG at baseline (median=7448), 6 weeks (median = 7799) and 24 weeks (median = 8233) however |
| Yates et al (2015) | Actiheart (CamNTech Company, UK). | Chest. 7 days at each data collection point (baseline, 3 and 6 months), measures energy expenditure, no other data reduction given. | PA behavior = average weekly level of PA spent in METs of 3 or more (time in moderate physical activity (min/wk ≥3.0 METs), dietary intake behaviors and biomarkers at baseline, post-CR (3 months) and follow-up (at 6 months). | Patients: physical activity (min/wk >3 METs) from baseline, post CR and between 3 months and 6 months (PaTH = 31.5, 89.3, 64.8, respectively and UC = 28.0, 133, 121.6, respectively). Patients did not meet 150 min/wk of moderate physical activity. |
| Ramadi et al (2016) | Sense Wear Mini Armband (BodyMedia, Pittsburgh, PA) | Upper arm, continuously for 5 days, removal for water activities. Data that was more than 80% of daily wear time included in analysis, sleep removed. Obtained 1-minute epochs. | Exercise capacity (6-minute walk test), no. of steps per day, energy expenditure, sedentary time (h/d and % of waking hours), light PA (h/d and % of waking hours), MVPA (min/d) and MVPA10+ in continuous 10-minute bouts (10+ min/d at baseline, 12 weeks after program, and at 6 months after program). | Exercise capacity in both groups showed significant improved compared to baseline and were maintained at 6 months ( |
| Ribeiro et al (2017) | Actigraph GT1M (ActiGraph LLC). | Hip. 7 days during waking hours. Remove for sleep and water activities. Used own developed software (POPERO version 1.0.18 for Mac OSX. to determine time spent in different intensity activities. 10 minutes of consecutive zeros = nonwear. Minimum 8 hours per day for a valid day. | Change in MVPA (min/d) after intervention. | EG increased MVPA after program: mean (SD) 43.2 (36.3) to 53.5 (31.9) min/d ( |
| ter Hoeve et al (2017) | ActiGraph GT3X+ (ActiGraph LLC). | Hip. 8 days at t0, t1, and t2 during waking hours. Taken off for water activities and recorded in logbook. Used vector magnitude. | Week before CR (t0) to after CR (t1) and at 12 months after the start of CR (t2). Change in total PA (activity counts/min, steps/min) and proportion of time spent awake in each activity (MVPA, light, and SB). Distribution of PA = lengths of MVPA and SB bouts, number of MVPA bouts >10 minutes, SB bouts >30 minutes (% of wear time). | Total activity counts/min mean (SD) difference: t0 − t1: +50.56 (128.2), |
| Prince et al (2018) | activPAL3 (PAL Technologies, Glasgow, UK). | Placed on right thigh and worn during waking time for seven days before first CR class. Valid data = minimum 4 valid days and 10 hours wear time per valid day. | Primary outcomes: intervention adherence. Secondary: change in sedentary time (ST) (min/d and % of wear time), steps (per day), MVPA (min/d). Measured before CR and in the last/8th week of CR. | No overall significant changes were observed in SB and PA. Average reduction in ST in IG (1.5%) and CG (1%) showed a mean difference in ST of 30.3 min/d (95% CI: −51.7, 112.2) favoring the IG ( |
| ter Hoeve et al (2018) | Actigraph GT3X+ (ActiGraph LLC). | Hip. Directly after randomization (T0), after CR (T3m), after after-care for 8 days during waking hours, used vector magnitude, at least 4 days with minimum 660 minutes per day. Nonwear = 60 minutes of consecutive zeroes. MVPA ≥672.5 counts, light activity = 37.5-672.5 counts, SB ≤ 37.5 counts. | Baseline directly after randomization (T0), post CR (T3m, 3 months after randomization), completion of after-care (T12m, 12 months after randomization), and 6 months after completion of after-care (T18m, 18 months after randomization). Duration of time spent in MVPA and SB as % of wear time, step count, MVPA bouts >10 minutes, SB bouts <30 minutes, number of patients attaining at least 6500 steps, and attaining 21.4 minutes prolonged MVPA/day. | CR + F vs CR-only: No overall intervention-effect for MVPA time and SB time. Overall intervention effect for step-count and prolonged MVPA (bout >10 minutes). At T3m, CR + F patients improved step count more than CR-only patients. During after-care program (3-12 month after CR) difference in step count not maintained. CR + T vs CR-only: no overall intervention effect. |
| Freene et al (2019) | ActiGraph ActiSleep, (Fort Walton Beach, FL, USA) | Right hip, worn for 24 h/d for 7 days. Nonwear defined as >60 consecutive minutes of zero activity, allowing for 2 minutes of counts between 0 and 100). Valid day was more than 10 h/d wear time and data included if 4 or more days of valid data. Freedson combination energy expenditure algorithm was used to determine PA and SB (<100 cpm) intensity cut-points. Used general time filter (07:00-22:30 hours. Average sleep and wake time reported by participants). | PA and SB time/day, MVPA bouts (minimum bout length = 10 minutes, tolerance of 2 minutes), SB bout time (minimum bout length 10 minutes but no drop time), number of breaks in sedentary time, adherence to AP recommendations. Measured at baseline, 6 weeks after CR and at a 6-month and 12-month follow-up. | Significant increase in MVPA from baseline to 12 months: 39 (23) to 45 (25) min/d. Significant increase in MVPA from 6 weeks to 6 months: 40 (24) to 44 (24) min/d. Significant increase in low physical activity from baseline to 6 weeks: 73 (22) to 82 (30) min/d, and to 12 months: 84 (26). Significant decrease in total SB time from baseline to 6 months: 723 (58) to 651 (81) min/d; and baseline to 12 months: 648 (79) min/d. Significant decrease in SB bouts and SB breaks from baseline to all time points. |
Abbreviations: CR, cardiac rehabilitation; NR, not reported; MVPA, moderate to vigorous physical activity; IG, intervention group; CG, control group; PA, physical activity; SB, sedentary behavior; ST, sitting time; VO2, oxygen consumption; cpm, activity counts per observation minute.
Figure 3.Forest plot of effect sizes for studies of pre-post exercise-based cardiac rehabilitation. The overall point estimate revealed a small effect favoring greater objective physical activity (PA) and sedentary behavior (SB) immediately following exercise-based cardiac rehabilitation. Arrow denotes the effect was greater than 1.
Figure 4.Forest plot of intervention versus control group for the change in activity behaviors following cardiac rehabilitation. The overall point estimate revealed a small effect favoring structured exercise-based cardiac rehabilitation versus nonexercise or alternative control interventions on objective physical activity (PA) and sedentary behavior (SB).
Figure 5.Forest plot of studies that included a long-term follow-up of activity outcomes versus baseline. The overall point estimate revealed a small effect favoring greater objective physical activity (PA) and sedentary behavior (SB) at longer term follow-up after completion of exercise-based rehabilitation.